Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double …
…, D Iacovelli, N Ishibashi, Y Iwabe, S Izumi… - The Lancet …, 2022 - thelancet.com
Background Early intramuscular administration of SARS-CoV-2-neutralising monoclonal
antibody combination, tixagevimab–cilgavimab, to non-hospitalised adults with mild to …
antibody combination, tixagevimab–cilgavimab, to non-hospitalised adults with mild to …
Japanese guideline for the treatment of idiopathic pulmonary fibrosis
…, A Azuma, S Sakamoto, K Sugino, Y Ishii, S Izumi… - Respiratory …, 2018 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology which accounts for a large
proportion of cases of idiopathic interstitial pneumonia. It has a very poor prognosis with a …
proportion of cases of idiopathic interstitial pneumonia. It has a very poor prognosis with a …
Mutations in the SLC34A2 Gene Are Associated with Pulmonary Alveolar Microlithiasis
Huqun, S Izumi, H Miyazawa, K Ishii… - American journal of …, 2007 - atsjournals.org
Rationale: Pulmonary alveolar microlithiasis is an autosomal recessive disorder in which
microliths are formed in the alveolar space. Objectives: To identify the responsible gene that …
microliths are formed in the alveolar space. Objectives: To identify the responsible gene that …
Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: the ISABELA 1 and 2 randomized clinical trials
Importance There is a major need for effective, well-tolerated treatments for idiopathic
pulmonary fibrosis (IPF). Objective To assess the efficacy and safety of the autotaxin inhibitor …
pulmonary fibrosis (IPF). Objective To assess the efficacy and safety of the autotaxin inhibitor …
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19
…, K Hayakawa, M Hashimoto, M Suzuki, S Izumi… - Gene, 2021 - Elsevier
COVID-19, a novel coronavirus-related illness, has spread worldwide. Patients with apparently
mild/moderate symptoms can suddenly develop severe pneumonia. Therefore, almost all …
mild/moderate symptoms can suddenly develop severe pneumonia. Therefore, almost all …
[HTML][HTML] Inhaled GM-CSF for pulmonary alveolar proteinosis
…, A Takahashi, M Oda, H Ishii, S Izumi… - … England Journal of …, 2019 - Mass Medical Soc
Background Pulmonary alveolar proteinosis is a disease characterized by abnormal
accumulation of surfactant in the alveoli. Most cases are autoimmune and are associated with an …
accumulation of surfactant in the alveoli. Most cases are autoimmune and are associated with an …
[HTML][HTML] The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice
…, J Hirashima, S Ishii, G Naka, J Takasaki, S Izumi… - PloS one, 2015 - journals.plos.org
Background Viral infection is one of the risk factors for asthma exacerbation. However, which
pathogens are related to asthma exacerbation in adults remains unclear. Objective The …
pathogens are related to asthma exacerbation in adults remains unclear. Objective The …
Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT. TB on active tuberculosis in Japan
…, Y Muto, M Hashimoto, M Iikura, S Izumi… - Journal of infection and …, 2018 - Elsevier
Background The QuantiFERON-TB Gold Plus (QFT-Plus) was introduced in 2015 as a new
generation of interferon-gamma release assays (IGRAs) designed to detect Mycobacterium …
generation of interferon-gamma release assays (IGRAs) designed to detect Mycobacterium …
[HTML][HTML] HLA-A* 11: 01: 01: 01, HLA-C* 12: 02: 02: 01-HLA-B* 52: 01: 02: 02, age and sex are associated with severity of Japanese COVID-19 with respiratory failure
…, T Suzuki, M Suzuki, S Suzuki, S Izumi… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing
coronavirus disease 2019 (COVID-19) was announced as an outbreak by the World Health …
coronavirus disease 2019 (COVID-19) was announced as an outbreak by the World Health …
Systematic review and meta-analysis of prognostic factors for idiopathic inflammatory myopathy-associated interstitial lung disease
H Kamiya, OM Panlaqui, S Izumi, T Sozu - BMJ open, 2018 - bmjopen.bmj.com
Objective To clarify prognostic factors for idiopathic inflammatory myopathy (IIM)-associated
interstitial lung disease (ILD). Design Systematic review and meta-analysis using the Grades …
interstitial lung disease (ILD). Design Systematic review and meta-analysis using the Grades …